Improving Purification Yields in APS Research

10 December 2014

Video review from Dr. Charis Pericleous, University College London, explaining the benefits of using the Amicon® Pro Purification System with her research. The research focuses on improving diagnosis and treatment of Antiphospholipid Syndrome (APS), specifically with regards to demonstrating pathogenicity in animal models of domain 1 antibody directed binding in β2 glycoprotein 1 (β2GPI), and its associated clinical manifestations. Utilising the Amicon Pro allowed for higher yields from crucial patient plasma, whilst simplifying the purification process and reducing time spent.